Diagnos Laboratorium Utama PT Tbk (DGNS) — Cash Flow Reinvestment Rate
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow Reinvestment Rate of 1.74x as of June 2025, reinvesting Rp2.64 Billion (capex Rp2.64 Billion ) from operating cash flow of Rp1.52 Billion. See cash generation quality of Diagnos Laboratorium Utama PT Tbk to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Diagnos Laboratorium Utama PT Tbk Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Diagnos Laboratorium Utama PT Tbk across 6 annual periods. For the full cash flow conversion analysis, see Diagnos Laboratorium Utama PT Tbk cash flow conversion.
Annual Cash Flow Reinvestment Rate for Diagnos Laboratorium Utama PT Tbk (2018–2024)
Year-by-year capital reinvestment analysis for Diagnos Laboratorium Utama PT Tbk. See DGNS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.59x | Rp43.39 Billion | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp38.32 Billion | Rp13.18 Billion | Rp38.32 Billion | ▲ +130.2% |
| 2021 | 1.26x | Rp74.35 Billion | Rp58.87 Billion | Rp67.84 Billion | ▲ +167.7% |
| 2020 | 0.47x | Rp12.37 Billion | Rp26.23 Billion | Rp5.86 Billion | ▼ -43.2% |
| 2019 | 0.83x | Rp9.29 Billion | Rp11.20 Billion | Rp2.78 Billion | ▼ -32.1% |
| 2018 | 1.22x | Rp10.34 Billion | Rp8.47 Billion | Rp3.84 Billion | — |